Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

BUY
$26.46 - $37.15 $6.86 Million - $9.64 Million
259,427 Added 16.7%
1,812,710 $61.6 Million
Q2 2021

Aug 16, 2021

SELL
$32.73 - $47.95 $1.88 Million - $2.75 Million
-57,400 Reduced 3.56%
1,553,283 $56.9 Million
Q1 2021

May 17, 2021

BUY
$40.39 - $56.73 $2.43 Million - $3.41 Million
60,183 Added 3.88%
1,610,683 $72.2 Million
Q4 2020

Feb 16, 2021

BUY
$51.77 - $66.18 $532,299 - $680,462
10,282 Added 0.67%
1,550,500 $88.5 Million
Q3 2020

Nov 16, 2020

SELL
$43.8 - $58.16 $1.25 Million - $1.65 Million
-28,451 Reduced 1.81%
1,540,218 $79 Million
Q2 2020

Aug 14, 2020

SELL
$37.05 - $65.03 $4.3 Million - $7.54 Million
-115,925 Reduced 6.88%
1,568,669 $93.7 Million
Q1 2020

May 15, 2020

SELL
$33.63 - $69.4 $291,303 - $601,142
-8,662 Reduced 0.51%
1,684,594 $69.4 Million
Q4 2019

Feb 14, 2020

SELL
$31.7 - $69.93 $2.11 Million - $4.66 Million
-66,594 Reduced 3.78%
1,693,256 $105 Million
Q3 2019

Nov 14, 2019

BUY
$19.95 - $38.85 $24.3 Million - $47.2 Million
1,215,553 Added 223.33%
1,759,850 $59.7 Million
Q2 2019

Aug 14, 2019

BUY
$21.05 - $26.21 $3.17 Million - $3.94 Million
150,365 Added 38.17%
544,297 $12.3 Million
Q1 2019

May 15, 2019

BUY
$20.65 - $29.55 $784,183 - $1.12 Million
37,975 Added 10.67%
393,932 $9.14 Million
Q4 2018

Feb 14, 2019

BUY
$19.08 - $36.14 $476,370 - $902,307
24,967 Added 7.54%
355,957 $7.47 Million
Q3 2018

Nov 14, 2018

BUY
$33.57 - $42.1 $557,027 - $698,565
16,593 Added 5.28%
330,990 $12.8 Million
Q2 2018

Aug 14, 2018

BUY
$20.06 - $44.95 $6.31 Million - $14.1 Million
314,397 New
314,397 $12.4 Million
Q1 2018

May 15, 2018

SELL
$20.04 - $29.71 $4.64 Million - $6.89 Million
-231,760 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$16.54 - $24.2 $504,056 - $737,495
30,475 Added 15.14%
231,760 $5.25 Million
Q3 2017

Nov 14, 2017

BUY
$17.65 - $18.99 $3.55 Million - $3.82 Million
201,285
201,285 $3.82 Million

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Arrow Mark Colorado Holdings LLC Portfolio

Follow Arrow Mark Colorado Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.